Epstein Secrets

blog.corn/lawfare-podcast-briefings-schmiefings> (9/2) podcast, Benjamin Wittes discusses the decision to end broad election security briefings with David Priess, "a former CIA briefer who used to do briefings like this, and Margaret Taylor, a former congressional staffer who used to consume briefings like t

https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria

information are scanty at best." In a Lawfare (9/2) podcast, Benjamin Wittes discusses the decision to end broad election security briefings with David Priess, "a former CIA briefer who used to do briefings like this, and Margaret Taylor, a former congressional staffer who used to consume briefings like th

or Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria

information are scanty at best." In a Lawfare (9/2) podcast, Benjamin Wittes discusses the decision to end broad election security briefings with David Priess, "a former CIA briefer who used to do briefings like this, and Margaret Taylor, a former congressional staffer who used to consume briefings like th

or Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria